0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Rimonabant :

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about NationDrugs.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Rimonabant:

  • Albania
  • Anguilla
  • Bosnia and Herzegovina
  • Cuba
  • Denmark
  • Dominican Republic
  • Ecuador
  • El Salvador
  • France
  • Germany
  • Greece
  • Greenland
  • Hungary
  • India
  • Iraq
  • Japan
  • Latvia
  • Liechtenstein
  • Lithuania
  • Mauritius
  • Moldova, Republic of
  • Norway
  • Panama
  • Portugal
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Trinidad and Tobago
  • Turkey
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Vanuatu
View All Countries

Latest news releases on Rimonabant:

Rimonabant - Wikipedia

Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that was first approved in Europe in 2006 but was withdrawn ...

Acomplia: Uses, Dosage, Side Effects & Warnings - Drugs.com

Sanofi-Aventis has withdrawn rimonabant from the market globally and it is no longer under development. 1 Acomplia was officially withdrawn by the European Medicines ...

Rimonabant - an overview | ScienceDirect Topics

Atrial fibrillation has been attributed to rimonabant in two cases [114 A]. • A man who took rimonabant for 5 weeks developed palpitation, fatigue, and exertional ...

European Medicines Agency - - Acomplia

European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.

Rimonabant | C22H21Cl3N4O - PubChem - The PubChem Project

Rimonabant is a pyrazole and piperidine derivative that acts as a selective cannabinoid type-1 receptor (CB1 RECEPTOR) antagonist. It inhibits the proliferation and ...

Acomplia (Rimonabant) – Investigational Agent for the ...

Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. It works...Read More...

Acomplia | Comprar Acomplia Rimonabant online na 121doc ...

Os pacientes obesos podem comprar Acomplia Rimonabant online em Portugal para perder peso. Oferecemos consulta médica gratuita e entrega pela farmácia.

Rimonabant — Wikipédia

Le rimonabant (ou SR141716) est un médicament anorexigène contre l'obésité agissant comme un agoniste inverse des récepteurs cannabinoïdes CB1.

Rimonabant – Wikipedia

Rimonabant ist ein Arzneistoff, der als Appetitzügler zur Behandlung des Übergewichts eingesetzt wurde, eigentlich allerdings zur Raucherentwöhnung von dem ...

Rimonabant - Wikipedia, la enciclopedia libre

Rimonabant (conocido también como SR141716), [n 1] es un inhibidor del apetito que actualmente se encuentra fuera del mercado en gran parte del mundo.

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2018 NationDrugs.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK